IBDEI135 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18451,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,18451,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,18452,0)
 ;;=C64.2^^79^879^38
 ;;^UTILITY(U,$J,358.3,18452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18452,1,3,0)
 ;;=3^Malig Neop of Left Kidney,Except Renal Pelvis
 ;;^UTILITY(U,$J,358.3,18452,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,18452,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,18453,0)
 ;;=C64.1^^79^879^39
 ;;^UTILITY(U,$J,358.3,18453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18453,1,3,0)
 ;;=3^Malig Neop of Right Kidney,Except Renal Pelvis
 ;;^UTILITY(U,$J,358.3,18453,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,18453,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,18454,0)
 ;;=C65.1^^79^879^40
 ;;^UTILITY(U,$J,358.3,18454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18454,1,3,0)
 ;;=3^Malig Neop of Right Renal Pelvis
 ;;^UTILITY(U,$J,358.3,18454,1,4,0)
 ;;=4^C65.1
 ;;^UTILITY(U,$J,358.3,18454,2)
 ;;=^5001251
 ;;^UTILITY(U,$J,358.3,18455,0)
 ;;=C65.2^^79^879^41
 ;;^UTILITY(U,$J,358.3,18455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18455,1,3,0)
 ;;=3^Malig Neop of Left Renal Pelvis
 ;;^UTILITY(U,$J,358.3,18455,1,4,0)
 ;;=4^C65.2
 ;;^UTILITY(U,$J,358.3,18455,2)
 ;;=^5001252
 ;;^UTILITY(U,$J,358.3,18456,0)
 ;;=C71.9^^79^879^42
 ;;^UTILITY(U,$J,358.3,18456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18456,1,3,0)
 ;;=3^Malig Neop of Brain,Unspec
 ;;^UTILITY(U,$J,358.3,18456,1,4,0)
 ;;=4^C71.9
 ;;^UTILITY(U,$J,358.3,18456,2)
 ;;=^5001297
 ;;^UTILITY(U,$J,358.3,18457,0)
 ;;=C83.50^^79^879^43
 ;;^UTILITY(U,$J,358.3,18457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18457,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,18457,1,4,0)
 ;;=4^C83.50
 ;;^UTILITY(U,$J,358.3,18457,2)
 ;;=^5001581
 ;;^UTILITY(U,$J,358.3,18458,0)
 ;;=C83.59^^79^879^44
 ;;^UTILITY(U,$J,358.3,18458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18458,1,3,0)
 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,18458,1,4,0)
 ;;=4^C83.59
 ;;^UTILITY(U,$J,358.3,18458,2)
 ;;=^5001590
 ;;^UTILITY(U,$J,358.3,18459,0)
 ;;=C83.70^^79^879^45
 ;;^UTILITY(U,$J,358.3,18459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18459,1,3,0)
 ;;=3^Burkitt Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,18459,1,4,0)
 ;;=4^C83.70
 ;;^UTILITY(U,$J,358.3,18459,2)
 ;;=^5001591
 ;;^UTILITY(U,$J,358.3,18460,0)
 ;;=C83.79^^79^879^46
 ;;^UTILITY(U,$J,358.3,18460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18460,1,3,0)
 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,18460,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,18460,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,18461,0)
 ;;=C81.90^^79^879^47
 ;;^UTILITY(U,$J,358.3,18461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18461,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,18461,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,18461,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,18462,0)
 ;;=C81.99^^79^879^48
 ;;^UTILITY(U,$J,358.3,18462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18462,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,18462,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,18462,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,18463,0)
 ;;=C82.90^^79^879^49
 ;;^UTILITY(U,$J,358.3,18463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18463,1,3,0)
 ;;=3^Follicular Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,18463,1,4,0)
 ;;=4^C82.90
 ;;^UTILITY(U,$J,358.3,18463,2)
 ;;=^5001541
 ;;^UTILITY(U,$J,358.3,18464,0)
 ;;=C82.99^^79^879^50
 ;;^UTILITY(U,$J,358.3,18464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18464,1,3,0)
 ;;=3^Folicular Lymphoma,Extranodal/Solid Organ Sites
